Ye Guolin, He Suqun, Pan Ruilin, Zhu Lewei, Zhou Dan, Lu RuiLiang
Department of Breast Surgery, The First People's Hospital of Foshan, Foshan 528000, China.
MRI Room, The First People's Hospital of Foshan, Foshan 528000, China.
J Healthc Eng. 2022 Feb 23;2022:4477099. doi: 10.1155/2022/4477099. eCollection 2022.
Breast cancer is a serious threat to women's physical and mental health. In recent years, its incidence has been on the rise and it has become the top female malignant tumor in China. At present, adjuvant chemotherapy for breast cancer has become the standard mode of breast cancer treatment, but the response results usually need to be completed after the implementation of adjuvant chemotherapy, and the optimization of the treatment plan and the implementation of breast-conserving therapy need to be based on accurate estimation of the pathological response. Therefore, to predict the efficacy of adjuvant chemotherapy for breast cancer patients is to find a predictive method that is conducive to individualized choice of chemotherapy regimens. This article introduces the research of DCE-MRI images based on deep transfer learning in breast cancer adjuvant curative effect prediction. Deep transfer learning algorithms are used to process images, and then, the features of breast cancer after adjuvant chemotherapy are collected through image feature collection. Predictions are made, and the research results show that the accuracy of the prediction reaches 70%.
乳腺癌严重威胁着女性的身心健康。近年来,其发病率呈上升趋势,已成为中国女性恶性肿瘤之首。目前,乳腺癌辅助化疗已成为乳腺癌治疗的标准模式,但反应结果通常需要在辅助化疗实施后才能完成,治疗方案的优化及保乳治疗的实施需要基于对病理反应的准确评估。因此,预测乳腺癌患者辅助化疗疗效就是要找到一种有利于个体化选择化疗方案的预测方法。本文介绍基于深度迁移学习的DCE-MRI图像在乳腺癌辅助疗效预测方面的研究。利用深度迁移学习算法对图像进行处理,然后通过图像特征采集收集辅助化疗后乳腺癌的特征,进行预测,研究结果表明预测准确率达到70%。